{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:06:48Z","timestamp":1794917208303,"version":"4.9.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cytomegalovirus (CMV) is the most frequent cause of congenital infection and \u224820% of all infected neonates present or will develop sensorineural hearing loss. Targeted congenital CMV (cCMV) screening in newborns who failed universal newborn hearing screening has been proposed as a strategy to identify neonates with both hearing loss and cCMV infection who could benefit from antiviral treatment implemented within the first month of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate the feasibility and performance of cCMV targeted screening in a French setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Neonates were recruited in 5 maternity centers in greater Paris. A saliva sample for CMV polymerase chain reaction (PCR) testing was collected in neonates who failed newborn hearing screening. Outcomes including CMV PCR result and confirmation of hearing loss by an otorhinolaryngologist specialist were documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Two-hundred thirty-six newborns were included and a saliva sample was collected in 98% (231\/236) of them. The result of CMV PCR was available at a median of 9 days (7\u201310 days) of life and in 96% of cases within the first month of life. Two neonates were infected with CMV. The result of the otorhinolaryngologist assessment was available in 75% (178\/236) of cases at a median of 16 days (9\u201326 days). Hearing loss was confirmed in 2.8% (5\/178). The 2 infected neonates had hearing loss confirmed at 5 and 8 days of life and were treated with valganciclovir at days 9 and 16, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The result of this study confirms that targeted cCMV screening is feasible in these French settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000003474","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T14:03:20Z","timestamp":1643551400000},"page":"478-481","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Performance of Targeted Congenital Cytomegalovirus Screening in Newborns Failing Universal Hearing Screening: A Multicenter Study"],"prefix":"10.1097","volume":"41","author":[{"given":"Jacques","family":"Fourgeaud","sequence":"first","affiliation":[{"name":"EA 73-28, Universit\u00e9 de Paris"},{"name":"AP-HP, Hospital Necker-E.M., Virology Department, Reference Laboratory for Cytomegalovirus Infections, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Boithias","sequence":"additional","affiliation":[{"name":"AP-HP, Hospital Bic\u00eatre, Neonatal Intensive Care Unit, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Walter-Nicolet","sequence":"additional","affiliation":[{"name":"INSERM, U1153, Epidemiology and Statistics Sorbonne Paris Cit\u00e9 Research Center; and Medicine and Neonatal Intensive Care Unit, Groupe Hospitalier Paris Saint Joseph, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Kermorvant","sequence":"additional","affiliation":[{"name":"AP-HP, Hospital Necker-E.M., Neonatal Intensive Care Unit, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Couderc","sequence":"additional","affiliation":[{"name":"Hospital Intercommunal Poissy-Saint Germain, Maternity, Poissy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Parat","sequence":"additional","affiliation":[{"name":"AP-HP, Hospital Cochin, Maternity, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pol","sequence":"additional","affiliation":[{"name":"AP-HP, Hospital Bic\u00eatre, Otology Department, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Mousset","sequence":"additional","affiliation":[{"name":"Hospital Saint Joseph, Otology Department, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Bussi\u00e8res","sequence":"additional","affiliation":[{"name":"EA 73-28, Universit\u00e9 de Paris"},{"name":"AP-HP, Hospital Necker-E.M., Clinical Research Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Guilleminot","sequence":"additional","affiliation":[{"name":"EA 73-28, Universit\u00e9 de Paris"},{"name":"AP-HP, Hospital Necker-E.M., Virology Department, Reference Laboratory for Cytomegalovirus Infections, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Ville","sequence":"additional","affiliation":[{"name":"EA 73-28, Universit\u00e9 de Paris"},{"name":"AP-HP, Hospital Necker-E.M., Maternity"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionelle","family":"Nkam","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Ambroise Par\u00e9, Unit\u00e9 de Recherche Clinique, Paris Saclay Ouest, Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamiae","family":"Grimaldi","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Ambroise Par\u00e9, Unit\u00e9 de Recherche Clinique, Paris Saclay Ouest, Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Parodi","sequence":"additional","affiliation":[{"name":"AP-HP, Hospital Necker-E.M, Otology Department, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Leruez-Ville","sequence":"additional","affiliation":[{"name":"EA 73-28, Universit\u00e9 de Paris"},{"name":"AP-HP, Hospital Necker-E.M., Virology Department, Reference Laboratory for Cytomegalovirus Infections, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection.","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajog.2020.02.018","article-title":"Cytomegalovirus infection during pregnancy: state of the science.","volume":"223","author":"Leruez-Ville","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.2014-1173","article-title":"Hearing loss and congenital CMV infection: a systematic review.","volume":"134","author":"Goderis","year":"2014","journal-title":"Pediatrics"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J Pediatr"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N Engl J Med"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archotol.128.1.11","article-title":"Surgery and functional outcomes in deaf children receiving cochlear implants before age 2 years.","volume":"128","author":"Hehar","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1044\/2014_AJSLP-13-0039","article-title":"Speech sound production in 2-year-olds who are hard of hearing.","volume":"23","author":"Ambrose","year":"2014","journal-title":"Am J Speech Lang Pathol"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"F230","DOI":"10.1136\/archdischild-2013-305276","article-title":"Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss.","volume":"99","author":"Williams","year":"2014","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/jpc.14428","article-title":"Integration of congenital cytomegalovirus screening within a newborn hearing screening programme.","volume":"55","author":"Beswick","year":"2019","journal-title":"J Paediatr Child Health"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"e20160789","DOI":"10.1542\/peds.2016-0789","article-title":"Outcomes from a hearing-targeted cytomegalovirus screening program.","volume":"139","author":"Diener","year":"2017","journal-title":"Pediatrics"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jpids\/pix105","article-title":"Results of a targeted screening program for congenital cytomegalovirus infection in infants who fail newborn hearing screening","volume":"8","author":"Vancor","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R14-20250615","article-title":"Performance and characteristics of the newborn hearing screening program in Campania region (Italy) between 2013 and 2019 [published online ahead of print March 25, 2021].","author":"Malesci","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00405-011-1672-1","article-title":"Universal newborn hearing screening, a revolutionary diagnosis of deafness: real benefits and limitations.","volume":"268","author":"Papacharalampous","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"e20200617","DOI":"10.1542\/peds.2020-0617","article-title":"Ethical and public health implications of targeted screening for congenital cytomegalovirus.","volume":"146","author":"Gievers","year":"2020","journal-title":"Pediatrics"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"e20162128","DOI":"10.1542\/peds.2016-2128","article-title":"A targeted approach for congenital cytomegalovirus screening within newborn hearing screening.","volume":"139","author":"Fowler","year":"2017","journal-title":"Pediatrics"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"e20183095","DOI":"10.1542\/peds.2018-3095","article-title":"Hearing loss with congenital cytomegalovirus infection.","volume":"144","author":"Foulon","year":"2019","journal-title":"Pediatrics"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"e20162610","DOI":"10.1542\/peds.2016-2610","article-title":"Hearing loss in children with asymptomatic congenital cytomegalovirus infection.","volume":"139","author":"Lanzieri","year":"2017","journal-title":"Pediatrics"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"F519","DOI":"10.1136\/archdischild-2016-311859","article-title":"Contribution of targeted saliva screening for congenital CMV-related hearing loss in newborns who fail hearing screening.","volume":"102","author":"Ari-Even Roth","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T12:00:19Z","timestamp":1749988819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003474","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}